LATS1 and central nervous system cancer: The tumor suppressor LATS1 is down regulated in various soft tissue sarcomas (Hisaoka et al., 2002), and LATS1 down-regulation was shown to be a poor prognostic factor in glioma cases (Ji et al., 2012).